AbbVie's drug for all types of hepatitis C wins EU approval
July 28, 2017 at 16:28 PM EDT
July 28 (Reuters) - AbbVie Inc said on Friday it had received European approval to market its drug for treatment of all six major forms of hepatitis C.
